Everolimus Krka

Everolimus Krka is an oral medication used for various therapeutic purposes. This pharmaceutical is manufactured by Krka, D.D., Novo Mesto, and is designed for oral use.

Everolimus Krka is primarily used to support immune system suppression and to aid in the prevention of organ rejection following transplants. It may also be used in the treatment of certain types of cancer, such as renal cell carcinoma and breast cancer. The medication works by inhibiting the growth of certain cells in the body, which can help to reduce the risk of rejection or slow the progression of cancer.

Common effects of Everolimus Krka may include fatigue, nausea, and mouth sores. Some users may also experience swelling in the limbs, difficulty breathing, or changes in blood sugar levels. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Everolimus Krka should be handled with care and stored according to the manufacturer's instructions. It is important to follow the prescribed dosage and administration guidelines to minimize the risk of side effects. Users should also be aware of potential interactions with other medications and inform their healthcare provider of all current treatments.

Everolimus Krka may interact with a variety of medications, including those that affect the immune system, blood thinners, and certain antibiotics. It is also important to avoid grapefruit and grapefruit juice, as they can increase the concentration of the medication in the body. Always consult a healthcare provider before starting or stopping any new medications.